한글목차

4가백신 시장 규모는 최근 몇 년간 크게 성장했습니다. 2025년 95억 1,000만 달러에서 2026년에는 104억 4,000만 달러에 이르고, CAGR 9.8%의 성장이 전망되고 있습니다. 지난 수년간의 성장세는 독감 확산, 정부의 백신 접종 정책, 백신 연구 발전, 독감 예방에 대한 일반 대중의 인식 개선, 선진국의 4가 백신 조기 도입 등이 주요 요인으로 꼽힙니다.

4가백신 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 153억 7,000만 달러에 이르고, CAGR은 10.1%를 나타낼 전망입니다. 예측 기간 동안의 성장은 광범위한 독감 예방에 대한 수요 증가, 백신 투여 기술 혁신, 신흥 시장에서의 예방접종 프로그램 확대, 생명공학 및 정밀의료에 대한 투자 증가, 유리한 상환 정책 및 정부 지원 등에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 백신 제형 최적화, 대상 연령층 확대에 따른 예방접종 프로그램, 콜드체인 및 유통 혁신, 다주형 독감 커버리지, 규제 준수 및 품질 보증 등이 있습니다.

세계 예방접종률 상승이 4가 백신 시장 성장을 견인할 것으로 예측됩니다. 예방접종률은 특정 기간 내에 특정 백신을 접종한 인구의 비율을 말합니다. 예방접종률이 확대됨에 따라 백신에 대한 수요가 증가함에 따라 한 번의 접종으로 여러 질병을 예방할 수 있는 4가 백신이 정기 예방접종 프로그램에 포함되는 경우가 많아지고 있습니다. 예를 들어, 세계보건기구(WHO)가 2025년 7월에 발표한 바에 따르면, 여아의 자궁경부암(HPV) 백신 접종률은 2023년 27%에서 2024년 31%로 상승했다고 합니다. 이러한 예방접종 커버리지 확대는 향후 4가 백신 시장의 성장을 뒷받침할 것으로 예측됩니다.

4가 백신 시장의 주요 기업들은 안전성 향상과 면역 반응 개선을 위해 나노입자 기술 등 혁신적인 백신 전달 기술에 집중하고 있습니다. 나노입자 기술은 살아있는 유전물질을 포함하지 않는 바이러스 유사 입자(VLPs)를 이용하여 바이러스의 외피 구조를 모방하여 안전성을 높인 기술입니다. 예를 들어, 2024년 3월 인도 기업 카디라 파마슈티컬스(Kadira Pharmaceuticals)는 첨단 4가 독감 백신(aQIV)을 출시했습니다. 이 백신은 2가지 A형(H1N1 및 H3N2) 및 2가지 B형 바이러스를 포함한 4가지 인플루엔자 바이러스 균주에 대한 방어력을 제공합니다. 이 제제는 특히 독감 유행 시기에 더 광범위한 유행 균주를 대상으로 하여 백신의 효능을 높입니다. 이는 독감 관련 이환율과 사망률 감소를 목표로 공중보건 성과를 개선하기 위한 지속적인 노력을 반영하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

A quadrivalent vaccine is designed to stimulate the immune system by responding to four different antigens, typically representing four distinct viruses or bacteria. Most commonly, quadrivalent vaccines are used to protect against four types of flu viruses, with two of them being type A and two being type B.

Quadrivalent vaccines are administered in different forms, including intradermal shots, intramuscular injections, and nasal sprays. An intradermal shot involves injecting the vaccine between the epidermis (top layer of skin) and hypodermis (bottom layer of skin), as per the Centers for Disease Control and Prevention (CDC). These vaccines are produced using various technologies such as conjugated, live, inactivated, recombinant, toxoid, and others. They are used for immunization against a wide range of diseases, including cancer, hepatitis, pneumococcal disease, COVID-19, influenza, human papillomavirus (HPV), meningococcal disease, polio, rotavirus, and more, serving both pediatric and adult populations. Distribution channels for these vaccines include hospitals, pharmacies, government suppliers, and other outlets.

Tariffs have influenced the quadrivalent vaccine market by increasing the cost of imported raw materials and vaccine components, affecting production timelines and supply chain efficiency. Regions heavily reliant on imports, such as Asia-Pacific and Africa, are most impacted, while segments like intramuscular and nasal spray vaccines face higher production costs. However, tariffs may encourage local manufacturing and sourcing strategies, potentially boosting domestic production capabilities and innovation in vaccine delivery solutions.

The quadrivalent market research report is one of a series of new reports from The Business Research Company that provides quadrivalent market statistics, including quadrivalent industry global market size, regional shares, competitors with a quadrivalent market share, detailed quadrivalent market segments, market trends and opportunities, and any further data you may need to thrive in the quadrivalent industry. This quadrivalent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quadrivalent market size has grown strongly in recent years. It will grow from $9.51 billion in 2025 to $10.44 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to growing prevalence of influenza, government vaccination initiatives, advances in vaccine research, increasing public awareness about flu prevention, early adoption of quadrivalent vaccines in developed regions.

The quadrivalent market size is expected to see rapid growth in the next few years. It will grow to $15.37 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to rising demand for broader influenza protection, innovations in vaccine delivery technologies, expansion of immunization programs in emerging markets, increasing investments in biotech and precision medicine, favorable reimbursement policies and government support. Major trends in the forecast period include vaccine formulation optimization, expanded age group immunization programs, cold chain and distribution innovations, multi-strain influenza coverage, regulatory compliance and quality assurance.

The rising immunization coverage across the globe is expected to drive the growth of the quadrivalent vaccine market. Immunization coverage refers to the proportion of the population that has received specific vaccines within a given timeframe. As immunization coverage expands, there is an increased demand for vaccines, and quadrivalent vaccines, which protect against four strains, are often integrated into routine vaccination programs to address multiple diseases in one shot. For example, in July 2025, the World Health Organization (WHO) reported that global coverage for the first dose of the HPV vaccine in girls grew from 27% in 2023 to 31% in 2024. This expanding immunization coverage will support the growth of the quadrivalent vaccine market moving forward.

Major companies in the quadrivalent vaccine market are focusing on innovative vaccine delivery technologies, such as nanoparticle technology, to enhance safety and improve immune response. Nanoparticle technology mimics the virus's outer structure using virus-like particles (VLPs), which do not contain live genetic material, thereby improving safety. For instance, in March 2024, Cadila Pharmaceuticals, an India-based company, launched the advanced Quadrivalent Influenza Vaccine (aQIV), which provides protection against four distinct strains of the influenza virus, including two A strains (H1N1 and H3N2) and two B strains. This formulation increases the vaccine's efficacy by targeting a broader range of circulating influenza strains, particularly during flu seasons. It aims to reduce influenza-related morbidity and mortality and reflects ongoing efforts to improve public health outcomes.

In February 2023, Clover Biopharmaceuticals Ltd., a China-based biotechnology company, partnered with Adimmune Corporation, a Taiwan-based biopharmaceutical firm, to leverage Adimmune's experience in manufacturing and distributing vaccines to Asian populations. This partnership supports Clover's goal of becoming a leader in respiratory vaccines while enhancing synergies with ongoing COVID-19 vaccine commercialization efforts.

Major companies operating in the quadrivalent market are AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Pfizer Inc., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG)

North America was the largest region in the quadrivalent market in 2025. The regions covered in the quadrivalent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the quadrivalent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quadrivalent market consists of sales of afluria quadrivalent, fluarix quadrivalent, flublok quadrivalent, fluzone quadrivalent (influenza virus vaccine), flulaval quadrivalent, flucelvax quadrivalent, menactra and menveo. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Quadrivalent Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses quadrivalent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quadrivalent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The quadrivalent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Intradermal Shot; Intramuscular Injection; Nasal Spray
• 2) By Technology: Conjugated; Live; Inactivated; Recombinant; Toxoid; Other Technologies
• 3) By Disease: Cancer; Hepatitis; Pneumococcal Disease; COVID-19; Influenza; Human Papilloma Virus; Meningococcal Disease; Polio; Rotavirus; Other Diseases
• 4) By Age Group: Pediatric; Adult
• 5) By Distribution Channel: Hospital And Pharmacy; Government Suppliers; Other Channels (NGOs)
• Subsegments:
• 1) By Intradermal Shot: Standard Intradermal Injection; Needle-Free Intradermal Delivery
• 2) By Intramuscular Injection: Standard Intramuscular Injection; Adjuvanted Intramuscular Injection
• 3) By Nasal Spray: Live Attenuated Nasal Spray; Inactivated Nasal Spray
• Companies Mentioned: AstraZeneca Plc; Serum Institute of India Private Limited; Sanofi S.A.; GlaxoSmithKline Plc; CSL Limited; Bharat Biotech International Limited; Hualan Biological Engineering Inc.; Merck & Co. Inc.; Johnson & Johnson Services Inc.; Pfizer Inc.; Walvax Biotechnology Co. Ltd.; Chongqing Zhifei Biological Products Co. Ltd.; Biological E. Limited; GSK Biologicals SA; Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences; Wuhan Institute of Biological Products Co. Ltd.; Beijing Tian Tan Biological Products Co. Ltd.; Shanghai Zhijiang Bio-pharm Co. Ltd.; Bio Farma; Butantan Institute; Pasteur Institute of India; China National Biotec Group Co. Ltd. (CNBG)
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Quadrivalent Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Quadrivalent Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Quadrivalent Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Quadrivalent Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Sustainability, Climate Tech & Circular Economy
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Vaccine Formulation Optimization
  • 4.2.2 Expanded Age Group Immunization Programs
  • 4.2.3 Cold Chain and Distribution Innovations
  • 4.2.4 Multi-Strain Influenza Coverage
  • 4.2.5 Regulatory Compliance and Quality Assurance

5. Quadrivalent Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Government Health Agencies
• 5.4 Pharmacies
• 5.5 Elderly Care Centers

6. Quadrivalent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Quadrivalent Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Quadrivalent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Quadrivalent Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Quadrivalent Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Quadrivalent Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Quadrivalent Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Quadrivalent Market Segmentation

• 9.1. Global Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Intradermal Shot, Intramuscular Injection, Nasal Spray
• 9.2. Global Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies
• 9.3. Global Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cancer, Hepatitis, Pneumococcal Disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases
• 9.4. Global Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pediatric, Adult
• 9.5. Global Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs)
• 9.6. Global Quadrivalent Market, Sub-Segmentation Of Intradermal Shot, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Standard Intradermal Injection, Needle-Free Intradermal Delivery
• 9.7. Global Quadrivalent Market, Sub-Segmentation Of Intramuscular Injection, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Standard Intramuscular Injection, Adjuvanted Intramuscular Injection
• 9.8. Global Quadrivalent Market, Sub-Segmentation Of Nasal Spray, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Live Attenuated Nasal Spray, Inactivated Nasal Spray

10. Quadrivalent Market Regional And Country Analysis

• 10.1. Global Quadrivalent Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Quadrivalent Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Quadrivalent Market

• 11.1. Asia-Pacific Quadrivalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Quadrivalent Market

• 12.1. China Quadrivalent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Quadrivalent Market

• 13.1. India Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Quadrivalent Market

• 14.1. Japan Quadrivalent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Quadrivalent Market

• 15.1. Australia Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Quadrivalent Market

• 16.1. Indonesia Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Quadrivalent Market

• 17.1. South Korea Quadrivalent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Quadrivalent Market

• 18.1. Taiwan Quadrivalent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Quadrivalent Market

• 19.1. South East Asia Quadrivalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Quadrivalent Market

• 20.1. Western Europe Quadrivalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Quadrivalent Market

• 21.1. UK Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Quadrivalent Market

• 22.1. Germany Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Quadrivalent Market

• 23.1. France Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Quadrivalent Market

• 24.1. Italy Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Quadrivalent Market

• 25.1. Spain Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Quadrivalent Market

• 26.1. Eastern Europe Quadrivalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Quadrivalent Market

• 27.1. Russia Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Quadrivalent Market

• 28.1. North America Quadrivalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Quadrivalent Market

• 29.1. USA Quadrivalent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Quadrivalent Market

• 30.1. Canada Quadrivalent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Quadrivalent Market

• 31.1. South America Quadrivalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Quadrivalent Market

• 32.1. Brazil Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Quadrivalent Market

• 33.1. Middle East Quadrivalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Quadrivalent Market

• 34.1. Africa Quadrivalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Quadrivalent Market, Segmentation By Type, Segmentation By Technology, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Quadrivalent Market Regulatory and Investment Landscape

36. Quadrivalent Market Competitive Landscape And Company Profiles

• 36.1. Quadrivalent Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Quadrivalent Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Quadrivalent Market Company Profiles
  • 36.3.1. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Serum Institute of India Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. CSL Limited Overview, Products and Services, Strategy and Financial Analysis

37. Quadrivalent Market Other Major And Innovative Companies

• Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Pfizer Inc., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., Bio Farma, Butantan Institute

38. Global Quadrivalent Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Quadrivalent Market

40. Quadrivalent Market High Potential Countries, Segments and Strategies

• 40.1 Quadrivalent Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Quadrivalent Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Quadrivalent Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer